The NanoBusiness Commercialization Association (NanoBCA) would like to share the following announcement from the National Nanotechnology Initiative (NNI).

NNI Releases Supplement to the President’s 2016 Budget
Budget provides $1.5 billion in funding;
details progress on NSIs, collaborations between Federal agencies

 The President’s Budget for Fiscal Year 2016 provides $1.5 billion for the National Nanotechnology Initiative (NNI), a continued Federal investment in support of the President’s priorities and innovation strategy. Cumulatively totaling more than $22 billion since the inception of the NNI in 2001, this funding reflects nanotechnology’s potential to significantly improve our fundamental understanding and control of matter at the nanoscale and to translate that knowledge into solutions for critical national needs.

2016-NNI-chartNearly half of the requested budget is dedicated to applications-focused R&D and support for the Nanotechnology Signature Initiatives (NSIs), reflecting an increased emphasis within the NNI on accelerating the transition of nanotechnology-based discoveries from lab to market. The NSIs are multiagency initiatives designed to accelerate innovation in areas of national priority through enhanced interagency coordination and collaboration. Furthermore, the NNI has continued to grow its hallmark environmental, health, and safety (EHS) activities, which now account for more than 10% of the NNI’s total budget (7% in dedicated EHS investments, as shown in the figure at left, plus approximately 3% in additional EHS-related investments within the NSIs).

“Right now, the NNI is focused on innovations that support national priorities, while maintaining a strong foundation of fundamental research in nanoscience,” says Dr. Michael Meador, Director of the National Nanotechnology Coordination Office. “Our goal is to create an environment to foster technology transfer and new applications today, while supporting the basic research that will provide a continuing pipeline of new discoveries to enable future revolutionary applications tomorrow.”

The President’s 2016 Budget supports nanoscale science, engineering, and technology R&D at 11 agencies; another 9 agencies have nanotechnology-related mission interests or regulatory responsibilities. The NNI Supplement to the President’s 2016 Budget documents activities of these agencies in addressing the goals and objectives of the NNI.

To view the full document, visit

Media Contact:
Marlowe Newman, Communications Director

NanoBCA-2015-DC-Roundtable-banner sm




The NanoBCA is honored to have the National Nanotechnology Coordination Office’s (NNCO) newly appointed Director, Dr. Michael A. Meador as a speaker at our 2015 NanoBCA DC Roundtable. Dr. Meador will speak on Tuesday, May 19th from 1:00-1:30pm on the first day of our event.  He will be joined by other prominent members of our Nanotechnology Community such as:

Stephen (Steve) B. Maebius, IP Partner & Nanotech Team Member, Foley & Lardner LLP
Dr. Gilberto M. (Ybet) Villacorta, Intellectual Property Department Chair, Washington DC Office, Foley & Lardner LLP
Doyle Edwards, Director, Government Programs, Brewer Science
Scott Rickert, Chairman & CEO, PEN Inc.
David Arthur, CEO, SouthWest NanoTechnologies Inc. (SWeNT)
Max Atanasov, CEO, OCSiAl LLC
Scott Livingston, Chairman & CEO, Livingston Securities LLC
Anil R. Diwan, Ph.D., President & Chairman, NanoViricides, Inc.
Jim Phillips, Chairman/CEO, NanoMech
Craig Bandes, CEO, Pixelligent Technologies, LLC
Carleton Hsia, Ph.D., Chairman & CEO, NanoBlood LLC
Mark Shaw, CEO, Ultratech, Inc.
Ronald Durando, Chariman, President & CEO, mPhase Technologies, Inc.
Frank Adell, CEO, Pharmaco-Kinesis Corporation


2015 NanoBCA DC Roundtable
May 19-20th
Washington, DC

We will be meeting with representatives from the White House Office of Science & Technology Policy (OSTP) on the second day of our event (Wednesday, May 20th).  There will be a panel discussion with members of Nanotechnology leaders such as:

Lynn L. Bergeson, Managing Partner, Bergeson & Campbell PC
Doug Jamison, Chairman of the Board, CEO & Managing Director, Harris & Harris Group, Inc.
Jess Jankowski, President & CEO, Nanophase Technologies Corp.
Chuck Van Fleet, President, Swan Chemical
Matthew Putman, Ph.D., CEO, Nanotronics Imaging
Glenn Kerner, Chair of the Nanotechnology Practice, Goodwin Procter LLP
Nilda Isidro, Partner, Food & Beverage & Products Liability Practices, Goodwin Procter LLP
John Bender, Chief Operating Officer, agencyIP
Philip H. Lippel, Ph.D., Assistant Director,  MIT Washington Office
Sam Brauer, Ph.D., Principal, Nanobiz LLC
Jeffrey Morse, Ph.D., Managing Director, National Nanomanufacturing Network

Fairfield Inn & Suites Washington, DC/Downtown
500 H St NW, Washington, DC 20001
888 236 2427
$299 per night (When Congress is in session, it is very expensive in Washington, DC with limited hotel availability)
When making reservations please refer to the room block name:
Nano Conference

Join NanoBCA in Washington, DC, May 19-20th, to learn about the issues at hand and to meet with and be heard by the key policy makers.

Looking forward to seeing you on May 19-20th in Washington, DC.


Vincent Caprio “Serving the Nanotechnology Community for Over a Decade”
Executive Director
NanoBusiness Commercialization Association